The Plus SideZ: A GLP-1 Guide to Metabolic Health

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Join our GLP-1 Support Group

______________________________________________________________________

"Both Our Advice and that of our Guest Expertalong with their insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you."

A Note Before You Listen: Our guest uses the term fat rather than obesity because that's the language of her community. At The Plus SideZ, we believe listening to different perspectives helps us better understand one another. If this language doesn't feel right for you, it's okay to honor that boundary and skip this episode.

The GLP-1 and body positivity communities are often portrayed as being at odds. But do they share more common ground than we realize?

In this episode, we sit down with Tigress Osborn, Executive Director of the National Association to Advance Fat Acceptance (NAAFA), to better understand the fat acceptance movement, the language it uses, and how it views obesity, GLP-1 medications, healthcare, body image, and weight stigma. 

Together, we explore where these communities differ, where they overlap, and whether listening to one another can lead to greater understanding.

Whether you agree or disagree, our goal isn't to debate or sway. It's to listen, learn, consider a different perspective, and better understand one another. 

Follow Tigress 

Instagram - https://www.instagram.com/iofthetigress/?hl=en 

Here book - https://www.amazon.com/Weight-Wisdom-Reflections-Decades-Liberation-ebook/dp/B0DRZ9R6XN

Learn more about Tigress Osborn and NAAFA:

• NAAFA: National Association to Advance Fat Acceptance (NAAFA)

• Socials: @naafaofficial

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials? 

www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials ______________________________________________________________________

*Both Our Advice and that of our Guest Experts along with their insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you.

This is a rapid fire FAQ about the Medicare Bridge Program and coverage of  with an obesity Doctor.

 Dr. Michael Albert an Obesity Medicine Specialist joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including:

• Who qualifies
• How the program works
• How to apply
• Options if you don't qualify

He also discusses:

• Weight loss with GLP-1s in older adults
• Protecting muscle mass and prioritizing protein
• Side effects to watch for
• What to advocate for with your doctor

Whether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance.

Follow Dr. Michael Albert

Instagram and TikTok:
 @michaelalbertmd

Website:
 MichaelAlbertMD.com
______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials? 

www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials ______________________________________________________________________

"Both Our Advice and our Guest Expert insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you."

How GLP-1s Broke Diet Culture

For decades, we believed weight gain and weight loss were mostly about willpower, calories, and exercise. Today, we’re learning there’s much more happening beneath the surface. The biology that drives hunger, metabolism, weight gain, and long-term health is far more complex than we once understood.

In this episode, Dr. Chiadi Ndumele, preventive cardiologist at Johns Hopkins Medicine and a leader with the American Heart Association, explains why GLP-1 medications work, how weight, metabolism, and chronic disease are connected, and why the first-ever Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline represents a major shift in how we understand and treat weight-related disease. You’ll also hear a powerful patient story that shows why this new understanding is giving hope to millions.

In this episode:

• Why GLP-1 medications work when diets often don’t.
• What really drives weight gain, weight loss, and long-term weight management.
• How metabolism, hormones, genetics, and overall health work together.
• Why understanding your body can help you advocate for the quality care you deserve.

Guest

Dr. Chiadi Ndumele

• Preventive Cardiologist, Johns Hopkins Medicine
• Chair, 2026 American Heart Association/American College of Cardiology Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline

Resources

American Heart Association: New Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline
https://www.heart.org/en/news/2026/06/09/new-ckm-guideline-urges-early-weight-talks-to-prevent-health-risks

Professional Heart Daily: 2026 Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
https://professional.heart.org/en/science-news/2026-guideline-for-the-prevention-detection-evaluation-and-management-of-ckm-syndrome

American Heart Association News Release: First-Ever Clinical Practice Guideline for Cardiovascular-Kidney-Metabolic Syndrome
https://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials?

www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials 

______________________________________________________________________

While Kim takes time away following the loss of her sister, we're revisiting some of our most impactful conversations from Season 1. Thank you for supporting The Plus SideZ Podcast and this community during this time.

Why do GLP-1 medications work when years of dieting and exercise often don't?

In this episode, obesity medicine physician Dr. Matea Rentea explains why obesity is more than willpower. Through expert insight and a powerful patient story, we explore the science behind obesity, metabolism, hormones, and why "eat less, move more" often isn't enough.

In this episode:
• Why diets fail for many people living with obesity
• How hormones and metabolism affect weight loss
• Why GLP-1 medications work differently
• The role of exercise, mental health, and weight stigma
• Real patient experiences alongside evidence-based medicine

Whether you're new to GLP-1s or have been with us since Season 1, this conversation remains one of our most requested episodes.

This episode was originally recorded in Season 1. Medical information reflects what was known at the time of recording. Always talk with your healthcare provider before making medical decisions. 

Follow Dr. Rentea
https://www.renteaclinic.com/ 

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials? www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials ______________________________________________________________________

Can GLP-1s Affect Food Noise, Alcohol, and Addiction?

** While Kim takes time away following the passing of her sister, we're revisiting some of our most impactful conversations. Thank you for your kindness, patience, and continued support of The Plus SideZ Podcast.

We're sharing this episode because it's more relevant today than when it first aired. Since then, research has expanded interest in whether GLP-1 medications may affect more than weight loss, including food noise, alcohol cravings, and other compulsive behaviors. While the science continues to evolve, so does the conversation.

Licensed therapist and addiction treatment leader Dr. Joy Bracey joins community member Brenda, who shares how Mounjaro changed her relationship with food, alcohol, and smoking. Together, they discuss the brain, behavior, and why this emerging area of research is drawing growing interest.

**In this episode:**

• Brenda's journey with obesity, binge eating, alcohol, smoking, and Mounjaro
• Food noise, binge eating, and emotional eating
• GLP-1 medications, dopamine, and the brain
• Alcohol cravings and addictive behaviors
• Mental health, self-love, and healing
• Why researchers are studying GLP-1 medications beyond weight loss

*Originally recorded during Season 1. This episode reflects the information available at the time of recording. Research and clinical guidance have continued to evolve. It is intended for education and discussion only and is not medical advice. Always consult your healthcare provider regarding your individual care.*

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials? 

www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials 

______________________________________________________________________

Will Medicare finally expand access to GLP-1 medications for obesity? How do you qualify? 

In this episode, Kim and Kat are joined by community co-host Deb Cooperman and DeeDee, a 70-year-old GLP-1 patient, to discuss Medicare coverage, weight loss, maintenance, and life on GLP-1s after 60.

Deb shares her experience paying cash for treatment while hoping to qualify for the new Medicare Bridge Program. DeeDee discusses maintaining her weight loss after losing access to medication, moving to compounded treatment, and growing up in a generation shaped by diet culture.

Topics include:

• GLP-1 medications after 60
• Weight loss and maintenance
• Medicare coverage and affordability
• Diet culture and obesity
• Long-term patient tips and lessons learned
• Access to obesity treatment

Obesity medicine specialist Dr. Michael Albert joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including:

• Who qualifies
• How the program works
• How to apply
• Options if you don't qualify

He also discusses:

• Weight loss with GLP-1s in older adults
• Protecting muscle mass and prioritizing protein
• Side effects to watch for
• What to advocate for with your doctor

Whether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance.

Follow Guests 

Follow Deb 

https://www.instagram.com/thedebcooperman 

https://www.instagram.com/thedebcooperman 

Follow Dee Dee

TikTok https://www.tiktok.com/@deesback  

Dr. Michael Albert

Instagram and TikTok:
 @michaelalbertmd

Website:
 MichaelAlbertMD.com

#GLP1 #Medicare #MedicareCoverage #ObesityMedicine #WeightLoss #HealthyAging #Zepbound #Wegovy

________________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:
___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 denials?
www.FindHonestCare.com/Kim

Ro - Telehealth for GLP1 Weight Management


GLP-1 Stall? Why Your Body Stops Losing Weight | Dr. Michelle Gordon

Hosts Kim Carlos and Kat Carter talk with obesity medicine specialist Dr. Michelle Gordon about the biological factors behind a GLP-1 weight loss plateau. If you are on a medication like tirzepatide or semaglutide and the scale stops moving, it is driven by a complex neuroendocrine response.

Dr. Gordon explains that the hypothalamus operates like a stubborn thermostat, defending a specific weight set point. When you lose weight, the brain reads the change as a threat and triggers physiological defenses. To prevent further weight loss, the body increases hunger hormones and simultaneously lowers its energy expenditure.

Key topics include:

• The Mechanism of a Stall: A weight plateau occurs at the exact point where your declining daily energy expenditure meets your rising natural hunger signals.
• Menopause and Fat Oxidation: Midlife hormonal shifts cause fat oxidation to drop, which alters metabolic burn rates and shifts fat storage to the stomach.
• The Chronic Disease Reality: Clinical data shows that stopping a GLP-1 medication typically results in regaining about two thirds of the lost weight, proving obesity requires continuous management.
• Muscle Mass Preservation: Rapid weight loss from any method causes muscle loss, making strength training essential to preserve lean muscle and protect long-term functional health.
  
  Connect to Dr. Michelle Gordon:
  
  Substack: https://drmichellegordon.substack.com/
  
  Instagram: https://www.instagram.com/doctormichellegordon/
  
  Facebook: https://www.facebook.com/drmichellegordon/
  
  Practice Website: https://drmichellegordon.com/
  
  LinkedIn: https://www.linkedin.com/in/drmichellegordon/
  ______________________________________________________________________
  
  Join this channel to get access to perks:
  
     / @theplussidez
  ______________________________________________________________________
  
  #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories
  
  
  
  
  

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Linktree for Community Resources

Need help appealing a GLP-1 Insurance Denial?
FindHonestCare.com/Kim

Ro - Telehealth for GLP1 Weight Management

The Absolute Lies You’ve Heard About GLP-1s (Ozempic Myths Debunked) [REPLAY]

Are you being lied to about Ozempic, Mounjaro, and Wegovy? In this special replay episode, leading obesity medicine specialists break down the biggest GLP-1 myths taking over your feed. We are reposting this crucial conversation because it is more relevant than ever. With GLP-1 price changes and expanding access options through federal programs like the Medicare GLP-1 Bridge, understanding the real science behind these medications is essential for patient advocacy.

We are sharing a few favorite replay episodes right now while Kim is away on bereavement leave following the loss of her sister. We want to deeply thank our subscribers for staying engaged and supporting the show during this time.

In this episode of The Plus Sidez Podcast, Kat joins Kim to sit down with obesity medicine specialists Dr. Matea Rentea and Dr. Ali Novitzki to help listeners better understand their disease and feel empowered in their healthcare journey.

The Myths We Debunk:

• The Muscle Loss Scare: The data behind weight loss and body composition, explaining why the medication itself is not destroying your lean mass.
• The Willpower Narrative: Why obesity is a genetic, chronic metabolic disease rooted in brain biology, not a failure of personal willpower.
• The Shot-Only Illusion: How the medication works alongside your body's natural satiety signals and gut receptors.
  
  

Obesity Doctor Guidance Shared:

• Metabolic Protection: A practical discussion on utilizing a 10-minute fitness routine and a 100-gram protein framework to maintain lean mass and support insulin sensitivity.
• System Navigation: Insights on navigating insurance barriers, managing prior authorizations, and advocating for proper medical care.

Mental Resilience: Tools to process unsolicited comments about your weight and protect your peace from societal judgment.


Episode Topics:

• Why We Are Replaying This Episode: Prices, Access, and Updates
• The Insurance Landscape: Understanding Prior Authorizations
• Meet the Obesity Medicine Specialists
• Deconstructing the GLP-1 Muscle Loss Narrative
• Strategies for Protecting Your Metabolism
• What the Scales Do Not Show About Insulin Resistance
• Natural Satiety Triggers and Gut Receptors
• Recognizing Obesity as a Biological Chronic Disease
• Addressing Weight Stigma and External Commentary

Subscribe to The Plus Sidez Podcast for science-backed episodes breaking down metabolic health, body recomposition, and the truth about weight loss.

Search Tags
GLP1 lies debunked, Ozempic myths, Mounjaro weight loss journey, Wegovy truth, Zepbound body recomposition, insulin sensitivity hacks, natural GLP1 boosters, treating obesity metabolic disease, plus sidez podcast, dr matea rentea, dr ali novitzki
_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Linktree for Community Resources

Need help appealing your GLP-1 insurance denials?
Try findhonestcare.com/kim

Ro - Telehealth for GLP1 Weight Management
_________________________________________________________________________

GLP-1 Over 60: Why This Feels Different Now Part 2
***Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode.


What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work?

In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around.

As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age.

What we cover:

- GLP-1 weight loss over 60
- Food noise and obesity beyond willpower
- Diet culture and lifelong messaging around weight
- Grief, stress, and emotional eating
- Protein, muscle preservation, and aging on GLP-1s
- Side effects and realistic expectations

Follow Deb

Follow Dr. Ogle
_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Linktree for Community Resources

Need help appealing your GLP-1 insurance denials?
Try findhonestcare.com/kim

Ro - Telehealth for GLP1 Weight Management and GLP-1

_________________________________________________________________________
***Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode.

What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work?

In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around.

As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age.

What we cover:

- GLP-1 weight loss over 60
- Food noise and obesity beyond willpower
- Diet culture and lifelong messaging around weight
- Grief, stress, and emotional eating
- Protein, muscle preservation, and aging on GLP-1s
- Side effects and realistic expectations

Follow Deb

Follow Dr. Ogle


_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram